Skip to content
LIVE MARKETS
--:--:--
ET
Testsite
Thoughts, stories and ideas.
40 filings/day — zero noise
Today's
stories · chronological wire
Search the wire
⌘K
Sign in
Subscribe
Home
HRMY
HRMY
1 story on the wire
HRMY
1 filing
Chronological · ET
13:05
HRMY
Harmony Biosciences Completes Phase 3 Cannabidiol Trial in Fragile X
The registry entry for Harmony's Phase 3 study of cannabidiol in Fragile X syndrome now shows a status of COMPLETED, updated 1 September 2026.
Clinical
Sep 2
10 days ago
PRO
No filings match.
Try another ticker or clear the filter.
LOAD EARLIER